Tirzepatide (Standard Pen) research pen
In stockResearch use only

Metabolic & Fat Optimization

Tirzepatide (Standard Pen)

Tirzepatide — dual GIP/GLP-1 agonist for next-tier metabolic research.

$174.00$217.50Save 20%
Pen size

12 pens for complete course · 1 pen lasts ~14 days

1
Suggested research dosage
Dose: 2,5 mg (can be increased up to 6 mg)/week. Units: 50 units/week.
Course
Once per week. From 6 months to as long as needed.
  • ✓ ≥99% purity (HPLC)
  • ✓ Batch-matched COA
  • ✓ Cold-chain 2–8°C
  • ✓ Tracked delivery
  • ✓ Tamper-evident
  • ✓ EU + US shipping
Overview

What is Tirzepatide (Standard Pen)?

Tirzepatide is a once-weekly dual agonist of GIP and GLP-1 receptors. SURMOUNT trials showed up to ~22.5% mean body-weight reduction at the 15 mg dose — currently the leading approved weight-loss agent.

Each PeptidePen is filled in a controlled cleanroom and sealed with tamper-evident packaging. Batch documentation includes identity confirmation, HPLC purity analysis and concentration verification. Strictly for in-vitro research — not for human or veterinary use.

Research library

Go deeper on Tirzepatide (Standard Pen)

A full breakdown of mechanism, clinical findings, dosing references and safety signals — for researchers who want the complete picture.

What is Tirzepatide?

Tirzepatide is a therapeutic peptide modeled after the hormone Glucagon, primarily prescribed for managing type 2 diabetes. Its structure features three lipophilic core modifications, resulting in a longer-lasting effect compared to other medications in its class. If you're aiming to control diabetes and prevent associated complications, purchasing Tirzepatide may offer significant benefits. — This advanced peptide helps individuals with type 2 diabetes regulate their blood glucose levels and lowers the risk of complications by mimicking the body's natural GLP-1 function. Tirzepatide enhances insulin production in the pancreas, improves insulin sensitivity, reduces glucose levels, and promotes a sense of fullness, which can curb appetite and help prevent fat accumulation. — Clinical research highlights Tirzepatide's potential for supporting healthy weight loss and overall vitality, making it an appealing option for those considering its use.

Continue reading the full research brief

How Tirzepatide Works

Tirzepatide stands out due to its dual-action mechanism, which makes it especially effective for diabetes management:

● Dual Receptor Activation: It acts on both GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory polypeptide) receptors, imitating the actions of natural hormones involved in regulating metabolism. — ● Blood Sugar Control: Tirzepatide encourages insulin release in response to high glucose levels, reducing post-meal blood sugar spikes. — ● Appetite Regulation and Weight Reduction: By delaying gastric emptying, it prolongs satiety and decreases hunger, leading to lower food intake and potential weight loss. — ● Enhanced Metabolic Function: This peptide improves how the body uses glucose and lipids. — ● Improved Pancreatic Beta-Cell Function: Tirzepatide supports healthier insulin responses over time by aiding pancreatic cell activity.

Altogether, these effects make Tirzepatide a comprehensive solution—not just for glycemic control, but also for metabolic wellness and weight management.

Benefits of Tirzepatide

When you opt to buy Tirzepatide, you may experience several key advantages:

● Significantly lowers blood glucose in type 2 diabetes patients — ● Aids in preventing diabetes-related complications — ● Promotes sustainable weight loss, especially in overweight individuals — ● Boosts fat metabolism and helps reduce fat buildup — ● Lowers the risk of cardiovascular issues common in diabetic patients — ● Helps regulate blood pressure levels — ● Supports kidney function and contributes to better renal health — ● May reduce risks of diabetic neuropathy and retinopathy — ● Enhances overall quality of life for those living with diabetes

Clinical Trial Insights

Tirzepatide has undergone extensive clinical evaluation, validating its safety and effectiveness:

● SURPASS-1: This Phase 3 study with over 4,500 participants found Tirzepatide superior to other diabetes drugs in blood glucose control and weight reduction. — ● SURMOUNT-1: A Phase 2 trial on 478 non-diabetic overweight patients showed significant weight loss across all subjects. — ● SURPASS-2: Involved 1,879 newly diagnosed diabetic patients, demonstrating substantial improvements in blood sugar levels. — ● Another clinical trial with 2,121 patients compared Tirzepatide to insulin treatment, revealing better outcomes in both weight loss and glycemic control for Tirzepatide users.

These findings underscore the peptide's effectiveness for those managing diabetes or weight challenges.

Proper Usage and Dosage of Tirzepatide (Pen)

To maximize the benefits of Tirzepatide, follow these recommended guidelines:

● Typical Weekly Dosage: 2.5 mg to 6 mg, adjusted based on personal health goals. Doses above 6 mg may be used if needed. — ● Application Instructions: Dial to your prescribed dose (1 unit = 1 division), apply into the abdomen or front thigh, and wait 10 seconds before removing the pen. Rotate the application site regularly.

Pen Duration Based on Dosage — ○ 5 mg pen: Lasts 1–2 weeks — ○ 10 mg pen: Lasts 2–3 weeks — ○ 15 mg pen: Lasts 4–5 weeks

Dosage Breakdown by Units: — 5 mg pen (100 units @ 50 mcg): — ○ 1 unit = 50 mcg — ○ 10 units = 500 mcg — ○ 20 units = 1 mg — ○ 50 units = 2.5 mg

10 mg pen (100 units @ 100 mcg): — ○ 1 unit = 100 mcg — ○ 10 units = 1 mg — ○ 25 units = 2.5 mg — ○ 50 units = 5 mg

15 mg pen (150 units @ 100 mcg): — ○ 1 unit = 100 mcg — ○ 25 units = 2.5 mg — ○ 50 units = 5 mg

These dosage guidelines help ensure safe and effective use.

Potential Side Effects

Like any medication, Tirzepatide may cause temporary side effects such as headaches or digestive discomfort, especially at the beginning of use or if dosing instructions are not followed. These reactions usually diminish over time. When used as directed, Tirzepatide is generally safe. Always consult a healthcare provider before combining with other medications or supplements.

Research highlights

Why researchers choose Tirzepatide (Standard Pen)

  • 01

    Dual incretin activation

  • 02

    Up to ~22.5% weight loss in trials

  • 03

    Superior HbA1c reduction vs. GLP-1 mono

  • 04

    Improved lipid and inflammation markers

Research protocol

Typical dosing reference

Weekly SC titration: 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg.

For in-vitro research design reference only.

Specifications

Specifications

Form

Pre-mixed pen

Purity

≥99% HPLC

Storage

2–8°C

Shipping

Cold-chain

COA

Batch-matched

Reported in research

Known side-effect signals

  • Nausea (titration-dependent)
  • Diarrhea
  • Decreased appetite
  • Injection-site reaction
From order to lab bench

Built for trust at every step

  1. 01

    Place your order

    Select pen size and shipping region at checkout.

  2. 02

    Verify the COA

    Each batch is HPLC-assayed and documented.

  3. 03

    Cold-chain ships

    Insulated, temperature-logged delivery.

  4. 04

    Run your protocol

    Reference dosing and references included.

FAQ

Frequently asked questions

Common questions about Tirzepatide (Standard Pen) and PeptidePen orders.

Is Tirzepatide (Standard Pen) for human use?+

No. All PeptidePen products are strictly for in-vitro laboratory research. Not intended for human or veterinary use.

How is the COA provided?+

Each pen ships with a batch-matched certificate of analysis. A digital copy is also available on request via your order confirmation.

How is shipping handled?+

Orders ship cold-chain (2–8°C) with insulated packaging, ice packs and a temperature log. Tracked delivery in the US and EU.

Can I order in bulk for my lab?+

Yes. Contact our team for institutional pricing, custom concentrations and recurring shipments.

What's your refund policy?+

Damaged or off-spec pens are replaced free of charge. Contact support within 7 days of delivery.

Ready to run Tirzepatide (Standard Pen) in your next study?

Pre-mixed, batch-assayed, cold-chain shipped — order before 2pm for same-day dispatch.

Related
View all →